X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 16c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.16). Revenue for the quarter came in at $2.71 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• ZenaTech raises Plurilock Security stake to 12% with new share purchase
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg